Study on efficacy of herbal drugs in reducing viral load in HIV/AIDS patients

Phase 2

Active, not recruiting

• Conditions: Human immunodeficiency virus [HIV]disease. Ayurveda Condition: RAJAYAKSHMA, (2) ICD-10 Condition: B20||Human immunodeficiency virus [HIV]disease. Ayurveda Condition: RAJAYAKSHMA,

• Registration Number: CTRI/2022/09/045548
• Lead Sponsor: MVR Ayurveda medical college

Brief Summary

this is a   randomized open ended comparative clinical trial, to evaluate the therapeutic efficacy of stericharm-HSA (external application) and steriswas-G1(for gargling). Both the drugs will be given to trial group, those with ART regime. This will be compared with the     control group under only ART. Viral load will be evaluated at before treatment, after 15 days and after 30 days of trial. Follow up evaluation will be done on 40th day.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-09-16
• Last Update Posted: 2023-06-10

Recruitment & Eligibility

• Status: Closed to Recruitment of Participants
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

those with ART regime and not under life threatening conditions.

Exclusion Criteria

those with serious systemic illness.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
reduction in viral load	Viral load will be evaluated before the treatment, after 15 days and after 30 days of treatment.

Secondary Outcome Measures

Name	Time	Method
Improvements in associated opportunistic confection and symptoms.Viral load measurement will be taken after 10days from stopping the Ayurveda regime (40th day)	Will be assessed before the treatment,after 15 days and 30 days of treatment. A follow-up evaluation will be done on 40th day.

Trial Locations

Locations (1)

MVR Ayurveda Medical college hospital; 🇮🇳 Kannur, KERALA, India

MVR Ayurveda Medical college hospital

🇮🇳Kannur, KERALA, India

Dr Shyam Prasad M

Principal investigator

9496192409

getshyampm@yahoo.co.in